IHC acquires additional stakes in Latin American food firm Grupo Nutresa: International Holding Company (IHC) has moved forward with its bid to absorb nearly 100% of Colombian food manufacturer Grupo Nutresa alongside partners through a share swap agreement and open market offer, it said in an ADX disclosure (pdf). The value of the two transactions — which bumped IHC’s stake in Nutresa to 14.83% — was not disclosed.

The details: IHC acquired a 2.45% stake in Nutresa after handing over its 2.03% stake in Colombian Grupo Sura via a share swap agreement. The company also snagged a 12.38% stake in Nutresa through Graystone Holdings, a firm representing IHC, which submitted an open market offer for the shares.

Background: IHC partner Grupo Gilinski and Graystone Holdings received offers for 22.48% of Nutresa in a public share offering at the start of the month. Prior to the share offer, Gilinski and IHC collectively held a 76.9% stake in Nutresa. The bids are part of a share swap agreement that was inked in 2023 between IHC, Nutresa, Sura and Argos. The agreement allows IHC and Gilinski to purchase 87% of Nutresa's shares in exchange for exiting their stakes in Sura.

OTHER M&A NEWS-

UAE medical services giant Response Plus Medical (RPM) finalized its acquisition of UK-based Prometheus Medical for unified defense and energy health solutions, according to an ADX disclosure (pdf). The value of the transaction was not disclosed.

Refresher: RPM had first announced its plan to acquire Prometheus back in January, with the aim of forming a global healthcare platform for energy and defense companies. The acquisition extends RPM's medical reach to global oil giants like Shell, Chevron, and UK defense sectors, while bolstering its medical fleet and accelerating UK and Nordic expansion. RPM will also be an official distributor of trauma care and simulation products from Safeguard Medical, Prometheus’ parent company, in the GCC and India.

No change in Prometheus’ corporate structure post-acquisition: Prometheus will maintain its separate identity and operations while being part of RPM’s portfolio, according to the statement. It'll rebrand its UK and Nordic operations as Prometheus Medical International, while UAE operations remain as Prometheus UAE. Steven Wines (LinkedIn) was tapped as CEO of Prometheus Medical International.

Mubadala appoints two new execs to Zamp’s board: Mubadala Capital retained Leonardo Armando Yamamoto as board chairman and appointed two new executives, including Zamp’s Brazil country head Oscar Pekka Fahlgren, to Brazilian food retailer Zamp’s board, according to a company disclosure (pdf). The company — in which Mubadala holds a 38.5% stake — also saw Affinity Partners — the private equity firm founded by Donald Trump’s son-in-law Jared Kushner — join after Asad Naqvi was elected as board member on Friday. This move follows Affinity Partners’ USD 200 mn investment in Zamp alongside Mubadala Capital, Bloomberg reported, citing people in the know.

REFRESHER- Mubadala increased its stake in Zamp to 38.5% (cc. 105.9 mn shares) in February after previously raising it to 20.4% in July 2023. The firm reportedly plans to consolidate Zamp with several foreign food franchises in Brazil through Mubadala Capital.

Tags: